Bayesian Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-740
| Closed | -$9.6K | – | 960 |
|
|
2023
Q4 | $9.6K | Buy |
+740
| New | +$9.6K | ﹤0.01% | 701 |
|
|
2023
Q2 | – | Sell |
-792
| Closed | -$46.2K | – | 941 |
|
|
2023
Q1 | $46.2K | Sell |
792
-2,117
| -73% | -$124K | 0.01% | 716 |
|
|
2022
Q4 | $148K | Buy |
+2,909
| New | +$148K | 0.02% | 632 |
|
|
2021
Q2 | – | Sell |
-1,800
| Closed | -$284K | – | 533 |
|
|
2021
Q1 | $284K | Buy |
+1,800
| New | +$284K | 0.07% | 360 |
|
|
2020
Q2 | – | Sell |
-937
| Closed | -$270K | – | 657 |
|
|
2020
Q1 | $270K | Buy |
+937
| New | +$270K | 0.06% | 495 |
|
|
2019
Q4 | – | Sell |
-673
| Closed | -$97K | – | 677 |
|
|
2019
Q3 | $97K | Buy |
+673
| New | +$97K | 0.02% | 478 |
|